Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:enzyme |
| gptkbp:administeredBy |
injection
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L03AX05
|
| gptkbp:brand |
gptkb:Adagen
|
| gptkbp:CASNumber |
93384-43-1
|
| gptkbp:hasUNII |
Q7Z6B7K4C0
|
| gptkbp:isPEGylated |
true
|
| gptkbp:isRecombinant |
true
|
| gptkbp:mechanismOfAction |
replaces deficient adenosine deaminase activity
|
| gptkbp:molecularWeight |
~540 kDa
|
| gptkbp:PubChem_CID |
DB00023
|
| gptkbp:routeOfAdministration |
intramuscular
|
| gptkbp:usedFor |
adenosine deaminase deficiency
|
| gptkbp:bfsParent |
gptkb:Adagen
|
| gptkbp:bfsLayer |
8
|
| http://www.w3.org/2000/01/rdf-schema#label |
pegademase
|